Product Highlight - Jeselhy

Active ingredient: Pimitespib

Indications: GI stromal tumor that has progressed after cancer chemotherapy including but not limited to imatinib, sunitinib, regorafenib.

Dosage & Administration: 160 mg once daily for 5 consecutive days, followed by 2 days off, & repeat. Dose reduction: 1st-level reduction: 120 mg daily. 2nd-level reduction: 80 mg daily. 3rd-level reduction: 40 mg daily.